Skip to main content
. 2016 Oct 12;14(5):4659–4665. doi: 10.3892/mmr.2016.5840

Figure 3.

Figure 3.

Alterations in the progressive motility of sperm treated with increasing concentrations of resveratrol. Semen samples from obese patients with astenospermia (60 cases) were treated with 0–100 µmol/l resveratrol for 30 min, and sperm motility was altered to varying degrees. Exposure to 30 µmol/l resveratrol demonstrated the most notable improvement in progressive motility compared with control and negative control samples. The control and negative control groups were treated with Quinn's Advantage™ Fertilization (HTF) Medium and Quinn's Advantage™ Fertilization (HTF) Medium plus 0.1% dimethyl sulfoxide, respectively.